ClinicalTrials.Veeva

Menu
L

Lisie Hospital | Department of Cardiovascular Clinical Research

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ziltivekimab
Verquvo
Semaglutide
Xarelto
Vericiguat
TRC150094
Rivaroxaban
BAY1021189
Apixaban
PF-07321332

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 14 total trials

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation (HERMES)

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get z...

Enrolling
Heart Failure
Drug: Placebo
Drug: Ziltivekimab

Approximately 216 patients with acute pancreatitis and accompanying SIRS will be randomized at approximately 30 sites. Patients will be randomly assi...

Active, not recruiting
Systemic Inflammatory Response Syndrome
Acute Pancreatitis
Drug: CM-4620 Injectable Emulsion or CM-4620-IE
Other: Placebo

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who hav...

Enrolling
Atherosclerotic Cardiovascular Disease (ASCVD)
Elevated Lp(a)
Drug: Lepodisiran Sodium
Drug: Placebo

Researchers are looking for a better way to treat people who have chronic heart failure with reduced ejection fraction (HFrEF).HFrEF is a long-term c...

Enrolling
Worsening Heart Failure
Chronic Heart Failure With Reduced Ejection Fraction
Drug: Vericiguat (Verquvo, BAY1021189)

The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivek...

Not yet enrolling
Acute Myocardial Infarction (AMI)
Cardiovascular Risk
Drug: Placebo
Drug: Ziltivekimab

Primary objective:- To evaluate the efficacy of oral reparixin versus standard care alone in limiting disease progression in adult patients hospitali...

Enrolling
Infectious Pneumonia
Severe COVID-19
Other: Placebo
Drug: Reparixin

This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with...

Enrolling
Chronic Kidney Disease
Inflammation
Drug: Placebo (Ziltivekimab B)
Drug: Placebo (Ziltivekimab C)

Trial sponsors

Novo Nordisk logo
Bayer logo
Abbott logo
C
Dompé logo
Lilly logo
Northwestern University logo
Pfizer logo
Torrent Pharma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems